For purine determinations, fibroblasts were detached by trypsinization, counted in a Neubauer chamber, and resuspended in 0.4 N PCA. For urine samples, 150 µl of supernatant were used and 5 µl of perchloric acid (PCA) 60% (6 N) were added to obtain a final concentration of 0.2 N PCA. The samples were kept on ice for 15 min and then centrifuged at 12,000×g for 5 min at 4 °C. Pellet obtained from fibroblast extraction was stored at − 20 °C for later protein quantification and supernatant from fibroblasts or urines was neutralized with 5 M potassium carbonate (Sigma-Aldrich, 209619) and filtered through PVDF micro spin filters (Thermo Scientific, F2517-5) via centrifugation at 10,000×g for 10 min at 4 °C. The supernatants filtered were kept at − 80 °C for HPLC determination. HPLC coupled to an UV detector was used for purine determinations. Analytes were separated using reverse-phase ion-pair chromatography on an Atlantis T3 column (Waters, 186003729). The optimized method for nucleotides separation and quantification consist on this sequence of stepped gradient of buffer A (10 mM of ammonium acetate (Sigma-Aldrich, A1542) and 2 mM of tetrabutylammonium phosphate monobasic solution (Sigma-Aldrich, 268100) pH5) and buffer B (10 mM of ammonium phosphate (Sigma-Aldrich, 09709), 2 mM of tetrabutylammonium phosphate, and 25% of acetonitrile (J.T. Baker, 76045) pH7) as follows: 100% of buffer A for 10 min, a linear gradient of buffer B up to 75% over 10 min, 9 min at 75% buffer B, a linear gradient to 100% buffer B over 3 min, 8 min at 100% buffer B, a linear gradient to 100% A in 1 min and finally 10 min maintained at 100% buffer A. The identification of purines was made by comparing their retention times to known standards and were quantified at 254 nm in a deuterium lamp. Sample analysis was performed by EZ Chrom Elite/ELITE UV–VIS software. To determine intracellular concentration of nucleotides, skin fibroblasts single cell volume (2 × 10–6 μl) was calculated empirically.
Escudero-Ferruz P., Ontiveros N., Cano-Estrada C., Sutcliffe D.J., Jinnah H.A., Torres R.J, & López J.M. (2024). A new physiological medium uncovers biochemical and cellular alterations in Lesch-Nyhan disease fibroblasts. Molecular Medicine, 30, 3.
Publication 2024
Corresponding Organization : Universitat Autònoma de Barcelona
Other organizations :
Emory University, Hospital La Paz Institute for Health Research, Centre for Biomedical Network Research on Rare Diseases, Instituto de Salud Carlos III
Resuspension of fibroblasts in 0.4 N perchloric acid (PCA)
Addition of 5 μL of 60% (6 N) perchloric acid (PCA) to 150 μL of urine samples to obtain a final concentration of 0.2 N PCA
dependent variables
Purine determinations
Intracellular concentration of nucleotides
control variables
Incubation of samples on ice for 15 minutes
Centrifugation of samples at 12,000 × g for 5 minutes at 4 °C
Neutralization of supernatant with 5 M potassium carbonate
Filtration of supernatant through PVDF micro spin filters at 10,000 × g for 10 minutes at 4 °C
HPLC coupled to UV detector for purine determinations
Reverse-phase ion-pair chromatography on Atlantis T3 column
Stepped gradient of buffer A (10 mM ammonium acetate, 2 mM tetrabutylammonium phosphate, pH 5) and buffer B (10 mM ammonium phosphate, 2 mM tetrabutylammonium phosphate, 25% acetonitrile, pH 7)
Identification of purines by comparing retention times to known standards
Quantification of purines at 254 nm
Analysis of samples using EZ Chrom Elite/ELITE UV–VIS software
Empirical calculation of skin fibroblasts single cell volume (2 × 10^-6 μL)
controls
Positive control: No information provided
Negative control: No information provided
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required